Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Onychomycosis Market Growth Evolved From 2024 To 2025, And What’s Ahead?

Over the past few years, the market size for onychomycosis has experienced a consistent expansion. It is anticipated to increase from $3.63 billion in 2024 to $3.81 billion the following year, reflecting a compound annual growth rate (CAGR) of 5.0%. The growth during the historic period could be linked to several factors such as restricted treatment alternatives, a rising aging population, escalated diabetes prevalence, growth in the pharmaceutical sector, and increased awareness concerning fungal infections.

The growth in the onychomycosis market sector is anticipated to solidify over the coming years, with projections suggesting it will reach an impressive$4.78 billion by 2029, evidencing a compound annual growth rate (CAGR) of 5.8%. This growth over the prediction period can be attributed to the rise in the use of combined drug therapies, an upsurge in healthcare spending, increased campaigns to raise awareness about onychomycosis, the broadening of telemedicine services, and breakthroughs in topical drug formulations. Significant trends during the prediction period encompass the incorporation of digital technologies for the diagnosis and management of onychomycosis, a surge in over-the-counter (OTC) antifungal products, the creation of treatment routines that are more accommodating to patients, a focus on personalized medicine for treating onychomycosis, and increased cooperation in research and development among pharmaceutical companies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12197&type=smp

What External and Internal Drivers Are Contributing to the Growth of theOnychomycosis Market?

The increasing occurrence of diabetes, a chronic condition marked either by inadequate insulin production from the pancreas or ineffective utilization of insulin by the body, is anticipated to drive the expansion of the onychomycosis market. People with diabetes frequently experience onychomycosis, a prevalent foot ailment which can be mitigated by properly managing and preventing any related complications. As a result, there is an increasing demand within the onychomycosis market. For example, in June 2024, the UK’s National Health Service reported that in 2023, over half a million (549,000) more people were identified as being at risk of developing type 2 diabetes, taking the total number of people with pre-diabetes, or non-diabetic hyperglycemia, registered with a GP to 3,615,330. This indicates a significant rise when compared to the 3,065,825 in 2022, exhibiting almost a 20% growth. Consequently, the increasing prevalence of diabetes is contributing to the growth of the onychomycosis market.

What Segment Types Define the Onychomycosis Market Structure?

The onychomycosismarket covered in this report is segmented –

1) By Type: Distal Subungual Onychomycosis (DSO); White Superficial Onychomycosis (WSO); Proximal Subungual Onychomycosis (PSO); Candida Onychomycosis; Other Types

2) By Treatment: Drug Treatment; Topical Therapy; Other Treatments

3) By Distribution Channel: Hospitals Pharmacies; Retail Pharmacies; Other Distribution Channels

Subsegments:

1) By Distal Subungual Onychomycosis (DSO): Dermatophyte Infections; Mixed Infections

2) By White Superficial Onychomycosis (WSO): Trichophyton Mentagrophytes Infections; Other Non-Dermatophyte Infections

3) By Proximal Subungual Onychomycosis (PSO): Associated with Nail Psoriasis; Fungal Infections In Immunocompromised Patients

4) By Candida Onychomycosis: Candidal Nail Infections; Mixed Fungal-Candida Infections

5) By Other Types: Total Nail Dystrophy; Secondary Onychomycosis

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12197&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Onychomycosis Market?

North America was the largest region in the onychomycosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the onychomycosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Onychomycosis Market?

The emergence of product innovation is a significant trend witnessed in the onychomycosis industry. Leading firms in the market are launching unique products to secure their market standing. For example, in January 2024, Vanda Pharmaceuticals Inc., a biopharmaceutical corporation based in the US, secured the FDA’s approval for VTR-297 to treat onychomycosis. VTR-297, a small molecule histone deacetylase (HDAC) inhibitor, exhibits antifungal activity, specifically targeting dermatophytes and other types of fungi. This action mode is key to effectively targeting the pathogens causing onychomycosis. The drug is meant for topical use, enabling direct application to the infected nails. This localized delivery system reduces systemic exposure and potential side effects linked to oral antifungal solutions.

View the full report here:

https://www.thebusinessresearchcompany.com/report/onychomycosis-global-market-report

What Is the Definition of the Onychomycosis Market?

Onychomycosis is a fungal infection that affects the nail matrix, bed, or plate, and can impact both toenails and fingernails, leading to discoloration, thickening, and nail crumbling. The goal of treatment is to eradicate the infection, restore the nail’s health and appearance, and prevent the fungus from spreading to other nails or skin.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12197

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model